- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 29, 2026 | 54.93M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 55.94M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 54.42M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $14.29M |
| Capex | Q1 2026 · Mar 31, 2025 | $10.79M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $15.22M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $23.97M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $285.16M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $345.19M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $539.71M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $635.55M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.21B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $1.2B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $1.03B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $1.32B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $762.48M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $808.07M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.31B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.41B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.01B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.1B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $2.52B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $2.61B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.40 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$6.01 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.41 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$6.01 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $143.57M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $129.15M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $58.7M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $37.88M |
| Net Income | Q1 2026 · Mar 31, 2026 | $22.29M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$327.32M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $41.47M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $48.62M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $243.75M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $216.25M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $118.51M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $100.6M |
| Revenue | Q1 2026 · Mar 31, 2026 | $362.26M |
| Revenue | Q1 2026 · Mar 31, 2025 | $316.86M |